Robert King's Net Worth
Estimate Recalculated Sep 9, 2024 12:37AM EST
Who is Robert King
Robert King has an estimated net worth of $5.71 Million. This is based on reported shares across multiple companies, which include Alector, Inc., and SCICLONE PHARMACEUTICALS INC.
SEC CIK
Robert King's CIK is 0001635264
Past Insider Trading and Trends
2016 was Robert King's most active year for acquiring shares with 6 total transactions. Robert King's most active month to acquire stocks was the month of September. 2020 was Robert King's most active year for disposing of shares, totalling 7 transactions. Robert King's most active month to dispose stocks was the month of July. 2021 saw Robert King paying a total of $549,000.00 for 154,541 shares, this is the most they've acquired in one year. In 2021 Robert King cashed out on 120,250 shares for a total of $1,873,422.50, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Form 4 | 6.79% | 35.96K | — | — | Oct 04, 2022 | 565.26K | Grant | — | Oct 01 |
Form 4 | -0.03% | -176.00 | $10.62 | -$1.87K | Sep 07, 2022 | 529.30K | Sale | — | Sep 02 |
Form 4 | -0.03% | -177.00 | $8.71 | -$1.54K | Jun 06, 2022 | 529.47K | Sale | — | Jun 02 |
Form 4 | -0.05% | -287.00 | $15.57 | -$4.47K | Mar 03, 2022 | 528.40K | Sale | — | Mar 01 |
Form 4 | -0.05% | -250.00 | $20.09 | -$5.02K | Dec 03, 2021 | 528.69K | Sale | — | Dec 01 |
Form 4/A | 1.14% | 5.94K | — | — | Oct 08, 2021 | 528.26K | Grant | — | Oct 01 |
Form 4 | 8.35% | 43.60K | — | — | Oct 04, 2021 | 565.92K | Grant | — | Oct 01 |
Form 4 | -7.77% | -60.00K | $20.15 | -$1.32M | Jul 07, 2021 | 712.32K | Sale | Scheduled | Jul 02 |
Form 4 | 9.43% | 45.00K | — | — | May 11, 2021 | 522.32K | Grant | — | May 07 |
Form 4 | — | 123.40K | — | — | Oct 05, 2020 | 123.40K | Grant | — | Oct 01 |
Form 4 | -3.05% | -15.00K | $27.00 | -$404.96K | May 19, 2020 | 477.32K | Sale | Scheduled | May 15 |
Form 4 | -2.96% | -15.00K | $29.56 | -$443.38K | Feb 18, 2020 | 492.32K | Sale | Scheduled | Feb 14 |
Form 4 | -2.87% | -15.00K | $22.01 | -$330.15K | Jan 23, 2020 | 507.32K | Sale | Scheduled | Jan 21 - Jan 22 |
Form 4 | -1.42% | -7.50K | $15.92 | -$119.40K | Nov 19, 2019 | 522.32K | Sale | Scheduled | Nov 15 |
Form 4 | — | 150.00K | — | — | Nov 08, 2019 | 150.00K | Grant | — | Nov 06 |
Form 4 | -1.40% | -7.50K | $15.00 | -$112.50K | Aug 21, 2019 | 529.82K | Sale | Scheduled | Aug 19 |
Form 3 | — | — | — | — | Feb 06, 2019 | 537.32K | — | — | — |
SCICLONE PHARMACEUTICALS INC
Form 4 | -41.42% | -44.67K | $7.47 | -$295.69K | Aug 16, 2016 | 63.18K | Sale | — | Aug 12 |
Form 4 | 700.00% | 56.00K | — | — | Mar 17, 2016 | 64.00K | Grant | — | Mar 15 |
Form 4 | — | 64.00K | — | — | Mar 18, 2015 | 64.00K | Grant | — | Mar 16 |
Form 3 | — | — | — | — | Mar 02, 2015 | 12.58K | — | — | — |
